How do medical device manufacturers' websites frame the value of health innovation? An empirical ethics analysis of five Canadian innovations.

While every health care system stakeholder would seem to be concerned with obtaining the greatest value from a given technology, there is often a disconnect in the perception of value between a technology's promoters and those responsible for the ultimate decision as to whether or not to pay for it. Adopting an empirical ethics approach, this paper examines how five Canadian medical device manufacturers, via their websites, frame the corporate "value proposition" of their innovation and seek to respond to what they consider the key expectations of their customers. Our analysis shows that the manufacturers' framing strategies combine claims that relate to valuable socio-technical goals and features such as prevention, efficiency, sense of security, real-time feedback, ease of use and flexibility, all elements that likely resonate with a large spectrum of health care system stakeholders. The websites do not describe, however, how the innovations may impact health care delivery and tend to obfuscate the decisional trade-offs these innovations represent from a health care system perspective. Such framing strategies, we argue, tend to bolster physicians' and patients' expectations and provide a large set of stakeholders with powerful rhetorical tools that may influence the health policy arena. Because these strategies are difficult to counter given the paucity of evidence and its limited use in policymaking, establishing sound collective health care priorities will require solid critiques of how certain kinds of medical devices may provide a better (i.e., more valuable) response to health care needs when compared to others.

Ethical aspects of cryobiology: responsible applications in biomedicine and in clinical practice.

This paper focuses on ethical issues in applications of cryobiology to humans, more particularly in the field of human reproduction and cryosurgery. The paper also provides essential ingredients for the interface of bioethics and cryobiology. For instance, since the 1970s bioethicists have developed four principles to guide the moral evaluation of the 'new medicine.' These are: respect for persons, non-maleficence, beneficence, and justice. In the field of human reproduction major progress was made by the cryopreservation of reproductive material. Still, ethical issues arise whenever partnerships cease to exist (death) or deteriorate (divorce), and decisions have to be made about the disposition of frozen gametes and embryos. Policy-making becomes, then, a prime concern. Examples of regulation in the United States of America, in the United Kingdom, and across Europe are being offered. Cryosurgery remains a field where cryobiologists struggle in their quest for an optimal technique, thus illustrating the need for assessment of safety, efficacy, and benefit to patients. Increasingly, cryobiologists have been joining in the ethical reflection on the use of cryo-technologies. They may further do so by perfecting their ability to identify ethical aspects, by analysing the norms and values at stake, by learning the skill of making the appropriate choices, and by showing their willingness to justify the choices made be it in the inner circle of pairs or publicly.